BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Treatment
54 results:

  • 1. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling.
    Singh DK; Carcamo S; Farias EF; Hasson D; Zheng W; Sun D; Huang X; Cheung J; Nobre AR; Kale N; Sosa MS; Bernstein E; Aguirre-Ghiso JA
    Cell Rep; 2023 Jun; 42(6):112560. PubMed ID: 37267946
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transcriptomic analysis of esophageal cancer reveals hub genes and networks involved in cancer progression.
    Chatterjee D; Rahman MM; Saha AK; Siam MKS; Sharif Shohan MU
    Comput Biol Med; 2023 Jun; 159():106944. PubMed ID: 37075603
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Roles of Nuclear Receptors in Esophageal cancer.
    Deng L; Liu J; Chen WD; Wang YD
    Curr Pharm Biotechnol; 2023; 24(12):1489-1503. PubMed ID: 36740804
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
    Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
    Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Robot-Assisted Reconstruction in head and neck Surgical Oncology: The Evolving Role of the Reconstructive Microsurgeon.
    Chalmers R; Schlabe J; Yeung E; Kerawala C; Cascarini L; Paleri V
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(3-4):178-185. PubMed ID: 30396171
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.
    Seidensaal K; Nollert A; Feige AH; Muller M; Fleming T; Gunkel N; Zaoui K; Grabe N; Weichert W; Weber KJ; Plinkert P; Simon C; Hess J
    Mol Cancer; 2015 Dec; 14():204. PubMed ID: 26634247
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic factors in oral and oropharyngeal cancer based on ultrastructural analysis and DNA methylation of the tumor and surgical margin.
    Mielcarek-Kuchta D; Paluszczak J; Seget M; Kiwerska K; Biczysko W; Szyfter K; Szyfter W
    Tumour Biol; 2014 Aug; 35(8):7441-9. PubMed ID: 24782031
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Case of pediatric acute promyelocytic leukemia presenting as extramedullary tumor of the mandible.
    Yamashita Y; Isomura N; Hamasaki Y; Goto M
    Head Neck; 2013 Oct; 35(10):E310-3. PubMed ID: 22972688
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Epstein-Barr Virus latent membrane protein 1 overcomes all-trans retinoic acid-induced apoptosis by inhibiting retinoic acid receptor-β₂ expression.
    Lee H; Seo SY; Tiwari I; Jang KL
    Biochem Biophys Res Commun; 2012 Jun; 423(2):313-8. PubMed ID: 22659417
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Model examination of chemoprevention with retinoids in squamous cell carcinomas of the head and neck region and suitable biomarkers for chemoprevention.
    Fabricius EM; Kruse-Boitschenko U; Schneeweiss U; Wildner GP; Hoffmeister B; Raguse JD
    Int J Oncol; 2011 Nov; 39(5):1083-97. PubMed ID: 21785820
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Retinoic acid enhances TRAIL-induced apoptosis in cancer cells by upregulating TRAIL receptor 1 expression.
    Dhandapani L; Yue P; Ramalingam SS; Khuri FR; Sun SY
    Cancer Res; 2011 Aug; 71(15):5245-54. PubMed ID: 21685476
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors.
    Durr ML; Mydlarz WK; Shao C; Zahurak ML; Chuang AY; Hoque MO; Westra WH; Liegeois NJ; Califano JA; Sidransky D; Ha PK
    PLoS One; 2010 May; 5(5):e10828. PubMed ID: 20520817
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment.
    Miasaki FY; Vivaldi A; Ciampi R; Agate L; Collecchi P; Capodanno A; Pinchera A; Elisei R
    J Endocrinol Invest; 2008 Aug; 31(8):724-30. PubMed ID: 18852534
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cellular senescence in oral cancer and precancer and treatment implications: a review.
    Campo-Trapero J; Cano-Sánchez J; Palacios-Sánchez B; Llamas-Martínez S; Lo Muzio L; Bascones-Martínez A
    Acta Oncol; 2008; 47(8):1464-74. PubMed ID: 18607883
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma.
    Liu YY; Stokkel MP; Morreau HA; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):605-9. PubMed ID: 17986279
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
    Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
    Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene.
    Koh CS; Ku JL; Park SY; Kim KH; Choi JS; Kim IJ; Park JH; Oh SK; Chung JK; Lee JH; Kim WH; Kim CW; Cho BY; Park JG
    Mol Cell Endocrinol; 2007 Jan; 264(1-2):118-27. PubMed ID: 17134824
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression of retinoid receptors in sebaceous cell carcinoma.
    Chakravarti N; El-Naggar AK; Lotan R; Anderson J; Diwan AH; Saadati HG; Diba R; Prieto VG; Esmaeli B
    J Cutan Pathol; 2006 Jan; 33(1):10-7. PubMed ID: 16441406
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma.
    Kwong J; Lo KW; Chow LS; To KF; Choy KW; Chan FL; Mok SC; Huang DP
    Neoplasia; 2005 Jan; 7(1):67-74. PubMed ID: 15720818
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha.
    Srinivas H; Juroske DM; Kalyankrishna S; Cody DD; Price RE; Xu XC; Narayanan R; Weigel NL; Kurie JM
    Mol Cell Biol; 2005 Feb; 25(3):1054-69. PubMed ID: 15657432
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.